1. Efficacy and safety of sequential treatment with botulinum toxin type A, fractional CO2 laser, and topical growth factor for hypertrophic scar management: a retrospective analysis
- Author
-
Jin Wang, Lijun Huang, Juan Li, Rui Xu, Tao Guo, Tong Huang, Yanping Wu, Yang Yang, Jiale Zhang, Feng Jiang, Huan Liu, Li Liang, and Lei Wang
- Subjects
Fractional CO2 laser ,Deep and active FX modes ,Botulinum toxin type A ,Hypertrophic scar ,Retrospective study ,Monotherapy ,Medicine ,Science - Abstract
Abstract Hypertrophic scars arise from aberrant wound healing and can lead to functional and aesthetic impairments. One of the common interventions for treating hypertrophic scars is fractional carbon dioxide (CO2) laser, which employs narrow laser beams to stimulate dermal collagen deposition. Recent studies and reports have suggested that combining laser therapy with other interventions such as botulinum toxin type A (BTX-A) and topical growth factors may enhance treatment outcomes. Here, we examine the efficacy and safety of a sequential combination of BTX-A, fractional CO2 laser, and topical growth factors, referred to as combined therapy, for treating hypertrophic scars compared with only using fractional CO2 laser and topical growth factors, referred to as monotherapy. Our retrospective study includes 128 patients with hypertrophic scars (56 underwent monotherapy and 72 underwent combined therapy), which were followed-up for up to 15 months after the initiation of treatment to collect demographic and clinical data. Our analysis showed that the combined therapy significantly outperformed monotherapy in improving Vancouver scar scale scores (P
- Published
- 2024
- Full Text
- View/download PDF